Tower Research Capital (TRC)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Sell |
|
|||||
|
2025
Q1 | $740K | Sell |
|
|||||
|
2024
Q4 | $1.12M | Buy |
|
|||||
|
2024
Q3 | $251K | Sell |
|
|||||
|
2024
Q2 | $2.12M | Buy |
|
|||||
|
2024
Q1 | $43.8K | Sell |
|
|||||
|
2023
Q4 | $337K | Sell |
|
|||||
|
2023
Q3 | $783K | Sell |
|
|||||
|
2023
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q1 | $520K | Buy |
|
|||||
|
2022
Q4 | $324K | Buy |
|
|||||
|
2022
Q3 | $73K | Sell |
|
|||||
|
2022
Q2 | $861K | Buy |
|
|||||
|
2022
Q1 | $736K | Buy |
|
|||||
|
2021
Q4 | $539K | Buy |
|
|||||
|
2021
Q3 | $111K | Sell |
|
|||||
|
2021
Q2 | $319K | Sell |
|
|||||
|
2021
Q1 | $1.73M | Buy |
|
|||||
|
2020
Q4 | $721K | Buy |
|
|||||
|
2020
Q3 | $473K | Buy |
|
|||||
|
2020
Q2 | $308K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $10K | Sell |
|
|||||
|
2019
Q3 | $79K | Sell |
|
|||||
|
2019
Q2 | $150K | Buy |
|
|||||
|
2019
Q1 | $60K | Buy |
|
|||||
|
2018
Q4 | $8K | Sell |
|
|||||
|
2018
Q3 | $633K | Buy |
|
|||||
|
2018
Q2 | $417K | Buy |
|
|||||
|
2018
Q1 | $151K | Sell |
|
|||||
|
2017
Q4 | $293K | Buy |
|
|||||
|
2017
Q3 | $107K | Buy |
|
|||||
|
2017
Q2 | $3K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $182K | Buy |
|
|||||
|
2016
Q1 | $99K | Buy |
|
|||||
|
2015
Q4 | $26K | Sell |
|
|||||
|
2015
Q3 | $78K | Sell |
|
|||||
|
2015
Q2 | $213K | Sell |
|
|||||
|
2015
Q1 | $505K | Buy |
|
|||||
|
2014
Q4 | $153K | Buy |
|
|||||
|
2014
Q3 | $2K | Sell |
|
|||||
|
2014
Q2 | $75K | Sell |
|
|||||
|
2014
Q1 | $272K | Sell |
|
|||||
|
2013
Q4 | $310K | Buy |
|
|||||
|
2013
Q3 | $179K | Buy |
|
|||||
|
2013
Q2 | $96K | Buy |
|